Biomolecules, 2021
Albumin Urinary Excretion Is Associated with Increased Levels of Urinary Chemokines, Cytokines, and Growth Factors Levels in Humans

Fellström B., Helmersson-Karlqvist J., Lind L. et al.

Scientific Reports, 2021
Disproportionate left atrial myopathy in heart failure with preserved ejection fraction among participants of the PROMIS-HFpEF study

Patel R., Lam C., Svedlund S. et al.

Journal of Cardiac Failure, 2021
Generalizability of HFA-PEFF and H2FPEF Diagnostic Algorithms and Associations With Heart Failure Indices and Proteomic Biomarkers: Insights From PROMIS-HFpEF

Faxen U., Venkateshvaran A., Shah S. et al.

Acta Neurologica Scandinavica, 2021
Urokinase, CX3CL1, CCL2, TRAIL and IL‐18 induced by interferon‐β treatment

Zhukovsky C., Herman S., Wiberg A. et al.

Inflammatory Bowel Diseases, 2021
Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease

Verstockt S., Verstockt B., Machiels K. et al.

Diabetes, 2021
Differences in Biomarkers of Inflammation Between Novel Subgroups of Recent-Onset Diabetes

Herder C., Maalmi H., Strassburger K. et al.

Cancers, 2021
A Phase II Study Demonstrates No Feasibility of Adjuvant Treatment with Six Cycles of S-1 and Oxaliplatin in Resectable Esophageal Adenocarcinoma, with ERCC1 as Biomarker for Response to SOX

Stroes C., Schokker S., Molenaar R. et al.

Biomarkers in Medicine, 2021
Associations of Serially Measured Pcsk9, Ldlr and Mpo with Clinical Outcomes in Heart Failure

Bouwens E., Schuurman A., Akkerhuis K. et al.

Frontiers in Bioengineering and Biotechnology, 2021
A LCMS Metabolomic Workflow to Investigate Metabolic Patterns in Human Intestinal Cells Exposed to Hydrolyzed Crab Waste Materials

Ó Fearghail F., Behan P., Engström N. et al.

Scientific Reports, 2021
Inflammatory profiles in Chilean Mapuche and non-Mapuche women with gallstones at risk of developing gallbladder cancer

Jackson S., Van De Wyngard V., Pfeiffer R. et al.

Journal of Inherited Metabolic Disease, 2021
Seizure phenotype in CLN3 disease and its relation to other neurologic outcome measures

Abdennadher M., Inati S., Soldatos A. et al.

The American Journal of Cardiology, 2021
Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (from the Atherosclerosis Risk in Communities Study)

Hussain A., Tang O., Sun C. et al.

The Journal of Infectious Diseases, 2021
Dysregulated Innate and Adaptive Immune Responses Discriminate Disease Severity in COVID-19

Janssen N., Grondman I., de Nooijer A. et al.

The Journal of Infectious Diseases, 2021
Long-Lasting Imprint in the Soluble Inflammatory Milieu Despite Early Treatment of Acute Symptomatic Hepatitis C

Khera T., Du Y., Todt D. et al.

Journal of Clinical Investigation, 2021
Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity

Falck-Jones S., Vangeti S., Yu M. et al.

Proceedings of the National Academy of Sciences, 2021
Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity

Kvedaraite E., Hertwig L., Sinha I. et al.

Angiology, 2021
Association of Epicardial Fat Volume With the Extent of Coronary Atherosclerosis and Cardiovascular Adverse Events in Asymptomatic Patients With Diabetes

Venuraju S., Lahiri A., Jeevarethinam A. et al.

Cancer Cell, 2021
Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients

Remsik J., Wilcox J., Babady N. et al.

Scientific Reports, 2021
Role of PAI-1 in hepatic steatosis and dyslipidemia

Levine J., Oleaga C., Eren M. et al.

International Journal of Cancer, 2021
Plasma protein biomarkers for early detection of pancreatic ductal adenocarcinoma

Yu J., Ploner A., Kordes M. et al.